News

The Alfred cuts risks in open heart surgery

24 October 2016

New research from The Alfred could nearly halve the number of people who suffer complications with bleeding following open heart and other major surgery. 

heart

research & innovation

Perils for passengers with nut allergies

19 September 2016

Preparing for air travel can be highly challenging for nut-allergic passengers, new research from The Alfred has revealed.

research & innovation

New treatment for hypertension being trialled

7 September 2016

A potentially life-changing one-off treatment for high blood pressure is currently being trialled at The Alfred. 

research & innovation

Alfred Health launches PrEPX

29 August 2016

More than 1300 Victorians have enrolled in an Alfred Health study that will provide unprecedented access to life-changing HIV prevention medication across the state.

hiv

research & innovation

TMS treatment shows breakthroughs for depression

11 July 2016

Researchers at the Monash Alfred Psychiatry Research Centre (MAPRC) at Alfred Health have released breakthrough findings that show one in two people respond positively to a non-medicated, non-invasive treatment for severe depression.

mental health

research & innovation

PrEPX study taking participants from July 26

5 July 2016

People across Victoria will be able to enrol in the highly-anticipated new pre-exposure prophylaxis study - known as PrEPX - from 26 July 2016, Alfred Health announced this week..

prepx

research & innovation

Scientists track effects of A2 milk on gut

27 June 2016

Scientists at The Alfred have established a world-first study to determine whether A2 milk really is easier to digest for some humans than regular dairy milk.

research & innovation

Treatment breakthrough for aggressive blood cancer

21 June 2016

Scientists from The Alfred and Monash University are hailing a drug designed to combat an aggressive blood cancer as one of the most promising advances against the disease in more than 40 years.

research & innovation

Alzheimer’s drug trial success

21 April 2016

Following the success of early research results of Anavex 2-73, a drug which aims to address the symptoms of dementia, Alfred Health is looking to continue a larger trial next year.

alzheimers

clinical trials

research & innovation

The Alfred leads world-wide aspirin study

25 February 2016

The long-held debate over the daily use of aspirin for patients at increased risk of heart attack and stroke has finally been answered, with researchers from around the world, led by The Alfred revealing it to be safe before surgery.

research & innovation